Nov 20, 2026
United States, November 20, 2026 /MarketersMEDIA/ -- Protheragen, a specialized Contract Research Organization (CRO) dedicated to preclinical obesity research, today announced the launch of its Obesity Microbiota Research Service, an end-to-end research solution designed to examine the relationship between gut microbiota and obesity. The service encompasses animal model development, sample collection, 16S rRNA gene sequencing and/or shotgun metagenomic sequencing, and advanced bioinformatics and analytics. Leveraging research in obesity, microbiomics, and systems biology, the service focuses on identifying and prioritizing microbial targets that can aid in the development of next-generation anti-obesity therapeutics for biotechnology and pharmaceutical companies.
Research indicates that imbalances in gut microbial populations can influence the development of metabolic disorders and obesity, and ongoing work aims to elucidate the mechanisms by which these microbial populations contribute to obesity and to develop therapeutic strategies that modulate them. Protheragen's Obesity Research Platform provides biotechnology and pharmaceutical companies with an integrated system to perform preclinical research on obesity and related disorders, facilitate the identification of therapeutic targets, and support the development of personalized microbiome-modulating strategies.
The Obesity Microbiota Research Service standardizes and streamlines its processes to provide clients with reproducible data. Once an appropriate animal model (e.g., mice or rats) is selected, the service can induce obesity using various means, including dietary manipulations, environmental modifications, and genetic manipulations. After sample collection (e.g., blood, feces, and intestinal tissues), the service provides specialized processing to protect the microbial contents and increase the precision of analysis. The service uses various techniques—including 16S rRNA gene sequencing, metagenomics, and metabolomics—to characterize microbial components and their metabolites, and to elucidate their effects on host physiology. Various bioinformatics and statistical tools are used to analyze the data and draw conclusions regarding the functional capabilities of the microbial components and their roles in obesity. This service provides clients with the ability to understand functionally important microbial components and groups, identify dysbiotic microbiota associated with obesity, and support the development of microbiota-based therapies for obesity.
Beyond microbiota-focused studies, the Obesity Microbiota Research Service is part of the broader Obesity Research Platform, which supports the entire spectrum of anti-obesity therapeutic development—including small-molecule drugs that modulate the gut microbiota, gene and cell therapies, antibody therapies, tissue engineering, and other transformative approaches. Rigorous preclinical validation is conducted to provide scientific justification for advancing a therapeutic candidate to clinical trials. Each candidate undergoes pharmacodynamic and pharmacokinetic studies, toxicological evaluation, and safety assessment, with bioanalytical support provided throughout.
About Protheragen
Protheragen is a specialized Contract Research Organization (CRO) dedicated to advancing preclinical research in obesity. Driven by a passion for scientific innovation and a commitment to client success, the company has established a reputation for delivering high-quality data, actionable insights, and tailored solutions that drive breakthroughs in obesity therapeutics. Its integrated Obesity Research Platform seamlessly combines expertise across metabolism, inflammation, and cardiovascular biology, enabling a holistic approach to obesity research and therapy development. The company maintains quality control standards throughout its preclinical services to support the integrity and regulatory acceptance of generated data. For more information about the Obesity Microbiota Research Service, please contact Protheragen.
Contact Info:
Name: Anna White
Email: Send Email
Organization: Protheragen
Website: https://www.obesityscientific.com/
Release ID: 89210336
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
This week FRANCE 24's media show "Scoop" looks at how the press covered the release of "Grand Theft Auto VI". Pre-orders and first-day sales totalled more than $2.3 billion. What does the game and the franchise's success mean for the future of entertainment? Our guest is Margaret Wallace, a video game developer and an associate professor of the practice of media innovation at Boston University.
Many women dread their partner coming down with 'man flu'. But before you lose all sympathy for your other half, it turns out that men really do tend to suffer more than women when they're sick.
The first-ever lease sale took place over the objections of a federal judge. Wetstone U.S. Ventures paid $6 million to lease the seabed for mapping and preparation, not actual mining.
A feline research center uses air-conditioning and pools to keep residents comfortable as their numbers recover. And yes, they like to swim.
An earthquake swarm has erupted along California's most infamous fault line, feared to unleash the 'Big One' within the next few years.
Grand Theft Auto 6 could be the biggest entertainment launch in history, as the blockbuster game shatters sales records.
China’s top market regulator has fined Baidu’s Hong Kong unit 500,000 yuan (US$75,000) for proceeding with its acquisition of part of live-streaming platform Joyy’s business before receiving antitrust clearance. The State Administration for Market Regulation (SAMR) said on Friday that Baidu (Hong Kong) had filed a merger notification for the deal as required by law, but implemented the transaction without waiting for official approval. The regulator ruled that the move had violated the...
Samsung Galaxy S25 Ultra's 256GB variant is now listed at around ₹88,388 on Flipkart, down from its launch price of ₹1,29,999. Bank discounts and exchange offers can bring the effective price down further for eligible buyers.
In an age when we're rarely more than a few inches away from our phones, some of the biggest clues of cheating could be hiding in plain sight - on WhatsApp.
CBS is reporting he has been fired after losing the confidence of White House chief of staff Stephen Miller.
The development marks a significant step in the company's international expansion strategy and could open opportunities in the growing US hearing healthcare market
The Daily Mail has exclusively obtained never-before-seen videos and once-secret files on UFOs as the Trump administration prepares to release its latest tranche of government records.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.